Malaria in Strasbourg University Hospital

University Hospital, Strasbourg, France70 enrolled

Overview

The primary purpose is to describe the anamnestic, clinical, biological, and therapeutic characteristics of imported malaria in people originated from endemic areas. Indeed, clinicians have observed that people from such areas start malaria just after their arrival in France. Such observation needed to be confirmed. In addition, The investigators observed a variation in the laboratory diagnostic performance of malaria between hospital and private laboratories. Such observation also needed to be analyzed objectively

Study Type

OBSERVATIONAL

Enrollment

Conditions

Malaria

Eligibility

Sex: ALLMin age: 1 Day

Medical Language ↔ Plain English

Inclusion Criteria:- Patient over 18 years * Patients from birth to 18 years * Patient submitted to guardianship * Patient submitted to trusteeship * Diagnosis patients with malaria from 01/01/2017 to 01/01/2018 * Patient or legal representative agree to use medical data for this research Exclusion Criteria: * Lack of confirmation malaria diagnosis * Impossibility to inform patients * Patient who does not wish to participate in the study * Patient submitted to justice safeguarding

Locations (1)

Service de Maladies Infectieuses et Tropicales

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Study of clinical characteristics of imported malaria in people originated from endemic areas hospitalized at Strasbourg University Hospital from 2017 to 2018.

Time frame: The period from January 1st, 2017 to January 1st, 2018 will be examined

Central Contacts

Xavier ARGEMI, MD

CONTACT

33 3 69 55 11 87 xavier.argemi@chru-strasbourg.fr

Anne DINDOYAL, MD

CONTACT

33 3 69 55 11 87 anne.dindoyal@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.